By CERBIOS-PHARMA SA
To get in touch with CERBIOS-PHARMA SA, simply fill out the form below.
Subscribe to Supplier
Cerbios-Pharma showcased its Pharmaceutical Services Portfolio at CPhI Worldwide
Lugano, Switzerland: – Cerbios-Pharma SA (Cerbios) successfully took part at CPhI Worldwide recently held in Milan and online.
The event resulted in an opportunity to resume a face to face relationship with the customers, after more than one year of virtual meetings and events.
The words from Hippocrate “If there is love for man, there will also be love for science”, were selected as closure banner for the event and perfectly summarize Cerbios philosophy which is applied in all the different fields covered by the company (Generic APIs, CDMO services and Probiotic FDF portfolio).
Cerbios introduced its participation to CPhI through a communication issued at the end of October and focused on Einstein phrase “Everything Should Be Made as Simple as Possible, But Not Simpler” which perfectly represents the company mindness.
ProveoTM (a division of Cerbios dedicated to Antibody Drug Conjugates) is an eminent example of how Cerbios aims to simplify its partners’ lives. The purpose of ProveoTM is to streamline the supply chain of all ADC components from payload and antibody to conjugation and fill and finish, all provided under the same organization. This one-to-one partnership means a saving in both cost and time.
Cerbios also offers services for HPAPIs and the approval of a new plant by Swissmedic in June 2021 is the latest addition to the company capabilities. This new production line is dedicated to non-cytotoxic highly active products with containment allowing OEL up to 30 ng/m3 and a manufacturing capacity of up to 35 kg batch size. The new plant is yet another step forward in Cerbios aim to provide support for its partners from clinical up to commercial scale for HPAPIs, optimize project timelines, and retain the process expertise acquired in the development stage. The Company’s “never stop” attitude towards meeting customer requirements is also represented by the new cytotoxic line (200gr-2kgs), which is under construction and due to be finalized within the next 12-18 months.
Probiotic FDF portfolio
Cerbios featured Hippocrates’ maxim “All diseases start in the intestine” as base for the launch of its new Food Supplements line.
For more than 40 years, Cerbios has been manufacturing and commercializing its proprietary strain E. faecium SF68® as a pharmaceutical drug for the treatment of diarrhea and dysbiosis.
With the efficacy and safety of the product supported by more than 20 clinical trials, Cerbios has continued over the years to characterize its strain and its use on various metabolic processes, strengthened further by association of vitamins and other ingredients.
Based on new scientific evidence, predictive of innovative therapeutic applications over the gut, Cerbios has combined its strain SF68® with vitamins, minerals, and other functional ingredients for a synergistic effect, developing cutting edge formulations backed by preclinical and clinical studies. These include two clinically proven food supplements that are ready to be out-licensed in international markets:
- SF68® ACNE: probiotic and niacin for the management of acne and seborrheic dermatitis.
- SF68® IMMUNO: probiotic, vitamins, and minerals to support the immune system. In vitro and in vivo data support the product’s efficacy on some respiratory viruses as well.
The above mentioned Products are ready to be out-licensed on exclusive basis for its Customers, in different markets. Cerbios will continue to diversify its portfolio of FDF in near future, with innovative products in different therapeutic areas.
Cerbios Pharma is glad to announce since now its participation to CPhI Worldwide 2022 in Frankfurt.
Cerbios is a privately held company located in Lugano, Switzerland, specialized in manufacturing Pharma Products and in offering CDMO services.
Cerbios is a global leading supplier of a portfolio of Generic APIs primarily used in Oncology and for the treatment of Respiratory and Dermatological disorders. Cerbios has additionally a 40 years’ experience in the probiotics field: the portfolio includes a FDF based on proprietary strain SF68® for treatment of diarrhea and dysbiosis by antibiotics and two new Food Supplements for the management of ACNE & Seborrheic dermatitis and to boost immune response.
Cerbios is also the ideal CDMO partner from clinical to commercial supply of API, HPAPIs, Payloads, ADCs, live Biotherapeutics, Proteins and Antibodies. Services offered include Process & Analytical Development, Scale-up and Clinical Supply, Industrial Validation, Commercial Supply, Full CMC Regulatory Support. Proveo (TM), is a Cerbios division recently created to provide end-to-end development and manufacturing services for ADCs.
Learn more at: https://cerbios.swiss .
About CPhI Worldwide 2021
Now in its 32nd year, CPhI Worldwide is the flagship European annual trade show for pharma ingredients and partner sourcing, as a one stop expo covering the entire industry, incorporating seven shows in one, also including the co-located zoned exhibitions; ICSE Outsourcing, P-MEC Machinery and Equipment, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and events and the new BioProduction.
CPhI Worldwide was last run as a physical event in 2019 in Frankfurt. The 2020 event, originally planned as a three-day event for October 2020 in Milan, Italy, was postponed due to the COVID-19 emergency Italy, and replaced by the 2020 CPhI Festival of Pharma as the world’s largest pharmaceutical virtual meeting, using online technologies to create a networking platform that will combine the world’s leading pharma companies, eminent speakers and extensive networking opportunities.
For 2021, CPhI Worldwide returned as a hybrid physical and online event, built around a three-day physical exhibition opening November 9 at the Fiera Milano exhibition center, accompanied by an online digital platform that ran from October 25 to November 19.
CPhI is organized by Informa Markets with further information at: https://www.cphi.com/europe/en/home.html
Click on Cerbios-Pharma at CPhI Worldwide Milan 2021 for further information.
Click on Cerbios-Pharma SA to see CPhI 2021 exhibitor profile.
Click on Cerbios-Pharma Drug Substances to explore full portfolio.
Email firstname.lastname@example.org to schedule a meeting with Cerbios-Pharma at CPhI Milan.